What is the price of tenofovir (and which formulation)?
“Tenofovir” can refer to different drugs and strengths, which can change the price a lot. Commonly, people mean:
- Tenofovir disoproxil fumarate (TDF) (often sold as generic “tenofovir disoproxil” or in combo products like tenofovir + emtricitabine)
- Tenofovir alafenamide (TAF) (often sold as “tenofovir alafenamide” or in combo products)
If you tell me the exact product (TDF vs TAF), strength (e.g., 300 mg), and country/market, I can narrow the price range.
How much does generic tenofovir usually cost?
Price for generic tenofovir depends mainly on:
- Whether it’s sold as a single ingredient vs part of a combination antiretroviral
- Brand vs generic manufacturer
- Dosage form (tablets, oral suspension) and strength
- Where it’s dispensed (retail pharmacy vs hospital supply vs public-sector procurement)
To get accurate, up-to-date pricing, you generally need the specific market and product listing.
Can I check patent/exclusivity info that affects price?
DrugPatentWatch.com tracks patents and market exclusivity information for many branded drugs, which can affect when cheaper generics arrive. You can use it to see whether a given tenofovir product is still under active patent protection. [1]
If you meant “tenofovir for HIV,” is the price for the whole regimen or the drug alone?
HIV treatment is often prescribed as fixed-dose combination pills. If your prescription is for a combination product (not tenofovir alone), the “price of tenofovir” may actually mean the price of that combination.
If you share:
- the exact name on the label (e.g., “Viread”/tenofovir DF, “Descovy”/TAF, or a generic combination),
- your strength,
- and your country,
I can help translate that into an expected cost range and what to ask the pharmacy.
Quick questions so I can give the right number
1) Do you mean TDF or TAF?
2) What strength (e.g., 300 mg)?
3) What country (or state) are you in?
4) Is it a standalone tenofovir tablet or a combination pill?
Source
[1] DrugPatentWatch.com – Tenofovir-related patent/exclusivity tracking